Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1973 2
1975 1
1978 1
1979 1
1980 1
1981 4
1982 1
1983 1
1984 2
1985 5
1986 1
1988 4
1989 3
1990 4
1991 2
1992 9
1993 3
1994 8
1995 5
1996 16
1997 10
1998 30
1999 53
2000 45
2001 54
2002 72
2003 86
2004 79
2005 117
2006 108
2007 107
2008 94
2009 97
2010 97
2011 99
2012 108
2013 79
2014 79
2015 46
2016 61
2017 59
2018 56
2019 56
2020 64
2021 74
2022 54
2023 47
2024 43
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,880 results

Results by year

Filters applied: . Clear all
Page 1
Intermittent and mild persistent asthma: how therapy has changed.
Di Cicco ME, Leone M, Scavone M, Miraglia Del Giudice M, Licari A, Duse M, Brambilla I, Ciprandi G, Caffarelli C, Tosca M. Di Cicco ME, et al. Acta Biomed. 2021 Nov 29;92(S7):e2021523. doi: 10.23750/abm.v92iS7.12422. Acta Biomed. 2021. PMID: 34842585 Free PMC article. Review.
In the last few years much attention has been focused on research on severe asthma and the role of biologicals in its treatment, also in children. However, mild asthma is way more common in childhood and still causes as many as 30-40% of asthma exacerb …
In the last few years much attention has been focused on research on severe asthma and the role of biologicals in its treatment, also …
Classification of asthma.
Padem N, Saltoun C. Padem N, et al. Allergy Asthma Proc. 2019 Nov 1;40(6):385-388. doi: 10.2500/aap.2019.40.4253. Allergy Asthma Proc. 2019. PMID: 31690376 Review.
Asthma can be classified into either intermittent or persistent, and the latter is either mild, moderate, or severe. Some patients change, in either direction, from intermittent to persistent asthma. In addition, patients with asthma may …
Asthma can be classified into either intermittent or persistent, and the latter is either mild, moderate, or severe. So …
Asthma remission: what is it and how can it be achieved?
Thomas D, McDonald VM, Pavord ID, Gibson PG. Thomas D, et al. Eur Respir J. 2022 Nov 3;60(5):2102583. doi: 10.1183/13993003.02583-2021. Print 2022 Nov. Eur Respir J. 2022. PMID: 35361633 Free PMC article. Review.
Even in those who develop a symptomatic remission of asthma, persistent pathological abnormalities are common, leading to a risk of subsequent relapse at any time. ...The factors associated with remission include mild asthma, better lung function, bett …
Even in those who develop a symptomatic remission of asthma, persistent pathological abnormalities are common, leading to a ri …
Japanese guidelines for adult asthma 2020.
Nakamura Y, Tamaoki J, Nagase H, Yamaguchi M, Horiguchi T, Hozawa S, Ichinose M, Iwanaga T, Kondo R, Nagata M, Yokoyama A, Tohda Y; Japanese Society of Allergology. Nakamura Y, et al. Allergol Int. 2020 Oct;69(4):519-548. doi: 10.1016/j.alit.2020.08.001. Epub 2020 Sep 4. Allergol Int. 2020. PMID: 32893125 Free article. Review.
Long-term management with therapeutic agents and the elimination of the triggers and risk factors of asthma are fundamental to its treatment. Asthma is managed by four steps of pharmacotherapy, ranging from mild to intensive treatments, depending on the sever …
Long-term management with therapeutic agents and the elimination of the triggers and risk factors of asthma are fundamental to its tr …
The allergic asthma phenotype.
Schatz M, Rosenwasser L. Schatz M, et al. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):645-8; quiz 649. doi: 10.1016/j.jaip.2014.09.004. Epub 2014 Nov 6. J Allergy Clin Immunol Pract. 2014. PMID: 25439351 Review.
The average age of onset of allergic asthma is younger than that of nonallergic asthma. Although the spectrum of allergic asthma may vary from mild to severe, studies have reported that allergic versus nonallergic asthma is less severe. ...Incre …
The average age of onset of allergic asthma is younger than that of nonallergic asthma. Although the spectrum of allergic a …
Understanding mild persistent asthma in children: the next frontier.
Bisgaard H, Szefler SJ. Bisgaard H, et al. J Allergy Clin Immunol. 2005 Apr;115(4):708-13. doi: 10.1016/j.jaci.2004.11.018. J Allergy Clin Immunol. 2005. PMID: 15805988 Review.
Limitations in asthma prevalence studies and difficulties in diagnosing pediatric asthma lead to uncertainty over the full extent of mild persistent asthma in children and adolescents. ...Thus, the true prevalence of mild asthma re …
Limitations in asthma prevalence studies and difficulties in diagnosing pediatric asthma lead to uncertainty over the full ext …
Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China.
Chen ZM, Zhao DY, Xiang L, Hong JG. Chen ZM, et al. World J Pediatr. 2021 Dec;17(6):619-625. doi: 10.1007/s12519-021-00464-7. Epub 2021 Oct 6. World J Pediatr. 2021. PMID: 34613593
METHODS: Data were derived from a retrospective questionnaire-based analysis of 2-14-year-old children with mild persistent asthma, who received either 500 g of BIS (n = 153) or 4-5 mg of montelukast (n = 240) once daily. ...CONCLUSION: Both treatments provid …
METHODS: Data were derived from a retrospective questionnaire-based analysis of 2-14-year-old children with mild persistent …
Hospital admission rate in children and adolescents with mild persistent asthma.
Ponte EV, Mingotti CFB, Mamoni RL, Marchi E, Martinelli JE, de Menezes MB, Vianna EDSO, Cruz ÁA. Ponte EV, et al. Pediatr Pulmonol. 2021 Jul;56(7):1889-1895. doi: 10.1002/ppul.25363. Epub 2021 Mar 15. Pediatr Pulmonol. 2021. PMID: 33721424
INTRODUCTION: The health and financial burden of mild-persistent asthma has been poorly investigated. OBJECTIVE: Our aim was to compare the rate of hospital admissions that have occurred during the preceding year between children and adolescents with current …
INTRODUCTION: The health and financial burden of mild-persistent asthma has been poorly investigated. OBJECTIVE: Our ai …
Mild persistent asthma. Traits, treatment set it apart from mild intermittent asthma.
Lim KG. Lim KG. Postgrad Med. 2004 May;115(5):40-6. doi: 10.3810/pgm.2004.05.1502. Postgrad Med. 2004. PMID: 15171077 Review.
Mild persistent asthma has greater airway hyperresponsiveness than mild intermittent asthma and may also have more persistent respiratory symptoms and more severe consequences. ...In this article, Dr Lim discusses how to differentiate …
Mild persistent asthma has greater airway hyperresponsiveness than mild intermittent asthma and may also …
Managing Asthma in Adolescents and Adults: 2020 Asthma Guideline Update From the National Asthma Education and Prevention Program.
Cloutier MM, Dixon AE, Krishnan JA, Lemanske RF Jr, Pace W, Schatz M. Cloutier MM, et al. JAMA. 2020 Dec 8;324(22):2301-2317. doi: 10.1001/jama.2020.21974. JAMA. 2020. PMID: 33270095
Compared with the 2007 guideline, there was no recommended change in step 1 (intermittent asthma) therapy (as-needed short-acting beta2-agonists [SABAs] for rescue therapy). In step 2 (mild persistent asthma), either daily low-dose ICS plus as-needed S …
Compared with the 2007 guideline, there was no recommended change in step 1 (intermittent asthma) therapy (as-needed short-acting bet …
1,880 results